CoChat

Severe Hyperlipidemia in Apolipoprotein E2 Homozygotes Due to a Combined Effect of Hyperinsulinemia and an Sst I Polymorphism

Sijbrands, Eric J. G., Hoffer, Mariëtte J. V., Meinders, A. Edo, Havekes, Louis M., Frants, Rune R., Smelt, Augustinus H. M., De Knijff, Peter · 1999 · Arteriosclerosis, Thrombosis, and Vascular Biology
Cited by 33

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Abstract —More than 90% of patients with type III hyperlipoproteinemia are homozygous carriers of the apolipoprotein (apo) E*2 allele. The great majority of these apoE2(Arg158→Cys) homozygotes in the general population, however, are normolipidemic. Apparently, expression of the hyperlipidemic state requires additional genetic and/or environmental factors, suggesting a multifactorial etiology. To elucidate these additional risk factors, we analyzed normolipidemic and hyperlipidemic apoE2 homozygotes. Hyperinsulinemia was observed in 27 of 49 apoE2 homozygotes and associated with elevated lipid levels: hyperinsulinemic apoE2 homozygotes had type III hyperlipoproteinemia 6 times more often than apoE2 homozygotes with normal insulin levels (odds ratio 6.2, P =0.02). We screened the normolipidemic and hyperlipidemic apoE2 homozygotes for common variants in candidate genes involved in lipolysis—the APOA1-C3-A4 gene cluster, lipoprotein lipase, and hepatic lipase—and analyzed for associations with the expression of hyperlipidemia. In the hyperinsulinemic group, the 7 carriers of the Sst I polymorphism (S2) in the APOC3 gene displayed severely elevated VLDL cholesterol ( P insulin by Sst I <0.001) and VLDL triglyceride ( P insulin by Sst I <0.01) and low levels of HDL ( P insulin by Sst I <0.02). In the normoinsulinemic group, no such relation of the Sst I polymorphism with hyperlipidemia was observed. These data provide the first evidence for a combined effect of hyperinsulinemia and the Sst I polymorphism on the expression of hyperlipidemia in apoE2 homozygotes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.19.11.2722

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 33

Metadata

Authors
Sijbrands, E. J. G., Hoffer, M. J. V., Meinders, A. E., Havekes, L. M., Frants, R. R., Smelt, A. H. M., & De Knijff, P.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
1999-11
Volume
19
Issue
11
Pages
2722-2729
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2127226744
Cited by
33
References
9
FWCI
1.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Severe Hyperlipidemia in Apolipoprotein E2 Homozygotes Due to a Combined Effect of Hyperinsulinemia and an Sst I Polymorphism. https://app.cochat.ai/papers/10.1161/01.atv.19.11.2722
The paper
Sijbrands, E. J. G., Hoffer, M. J. V., Meinders, A. E., Havekes, L. M., Frants, R. R., Smelt, A. H. M., & De Knijff, P. (1999). Severe Hyperlipidemia in Apolipoprotein E2 Homozygotes Due to a Combined Effect of Hyperinsulinemia and an Sst I Polymorphism. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.19.11.2722

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.